{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:16Z","timestamp":1791388996618,"version":"4.3.3"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>First described in Japan 50 years ago, Kawasaki disease is a worldwide multisystem disease. It is an acute self-limited vasculitis of unknown etiology that can lead to coronary artery lesions, such as dilatation, aneurysms, and stenosis in children. It is one of the common causes of acquired heart disease among children in developed countries. The coronary aneurysm is a severe complication in the acute stage, possibly leading to stenotic lesions or myocardial ischemia. More concerns have centered on endothelial damage and the early onset of atherosclerosis in patients with KD. Although the coronary artery aneurysm is small or degenerated, the vascular structure does not return to normal, vascular endothelial dysfunction and remodeling continue. Most patients diagnosed with coronary artery sequelae are at risk of long-term complications. There are still many unknown aspects regarding the long-term prognosis of patients. Concerns have centered on the early onset of atherosclerosis in patients with KD. There is still no consensus on the relationship between Kawasaki disease and atherosclerosis. This study aimed to evaluate if patients with a history of KD were at risk of accelerated atherosclerosis.<\/jats:p>","DOI":"10.3389\/fcvm.2021.671198","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T15:22:36Z","timestamp":1618586556000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["An Update on Cardiovascular Risk Factors After Kawasaki Disease"],"prefix":"10.3389","volume":"8","author":[{"given":"Yuan-Yuan","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1001\/jamapediatrics.2018.3307","article-title":"Diagnosis and management of Kawasaki disease","volume":"173","author":"Sosa","year":"2019","journal-title":"JAMA Pediatr."},{"key":"B2","article-title":"Kawasaki disease","volume-title":"StatPearls","author":"Modesti","year":"2021"},{"key":"B3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/MOP.0b013e32833e12f7","article-title":"Long-term prognosis of Kawasaki disease: increased cardiovascular risk?","volume":"22","author":"Fukazawa","year":"2010","journal-title":"Curr Opin Pediatr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jjcc.2008.11.006","article-title":"Endothelial dysfunction in a cohort of North Indian children with Kawasaki disease without overt coronary artery involvement","volume":"53","author":"Ghelani","year":"2009","journal-title":"J Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00431-007-0452-9","article-title":"Endothelial dysfunction in adult patients with a history of Kawasaki disease","volume":"167","author":"Niboshi","year":"2008","journal-title":"Eur J Pediatr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/adc.2006.096628","article-title":"Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease","volume":"92","author":"Cheung","year":"2007","journal-title":"Arch Dis Child."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00296-014-3000-8","article-title":"Aortic stiffness studies in children with Kawasaki disease: preliminary results from a follow-up study from North India","volume":"34","author":"Gupta","year":"2014","journal-title":"Rheumatol Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1536\/ihj.46.811","article-title":"Serum lipids in north Indian children treated for kawasaki disease","volume":"46","author":"Mitra","year":"2005","journal-title":"Int Heart J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2431-8-20","article-title":"Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness","volume":"8","author":"Cheung","year":"2008","journal-title":"BMC Pediatr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jjcc.2010.06.006","article-title":"Effects of HMG-CoA reductase inhibitors on continuous post-inflammatory vascular remodeling late after Kawasaki disease","volume":"56","author":"Hamaoka","year":"2010","journal-title":"J Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1161\/01.CIR.0000151311.38708.29","article-title":"Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease","volume":"111","author":"Mitani","year":"2005","journal-title":"Circulation."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001233","article-title":"Assessment of endothelial dysfunction in acute and convalescent phases of Kawasaki disease using automated edge detection software: a preliminary study from North India","author":"Routhu","year":"2019","journal-title":"J Clin Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12872-018-0765-9","article-title":"The association between oxidative stress and endothelial dysfunction in early childhood patients with Kawasaki disease","volume":"18","author":"Ishikawa","year":"2018","journal-title":"BMC Cardiovasc Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1542\/peds.2004-2182","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, Kawasaki Disease. Council on Cardiovascular Disease in the Young, American Heart Association","volume":"114","author":"Newburger","year":"2004","journal-title":"Pediatrics."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11926-020-00941-4","article-title":"Kawasaki disease: an update","volume":"22","author":"Rife","year":"2020","journal-title":"Curr Rheumatol Rep."},{"key":"B17","unstructured":"Division of Public Health, Jichi Medical UniversityNation-wide Survey for Kawasaki Disease"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","article-title":"JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease","volume":"84","author":"Fukazawa","year":"2020","journal-title":"Circ J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/INF.0b013e3181cf8705","article-title":"Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007","volume":"29","author":"Holman","year":"2010","journal-title":"Pediatr Infect Dis J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"m2094","DOI":"10.1136\/bmj.m2094","article-title":"Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study","volume":"369","author":"Toubiana","year":"2020","journal-title":"BMJ."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2020.10.008","article-title":"Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study","author":"Lima-Setta","year":"2020","journal-title":"J Pediatr (Rio J)."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2001010","DOI":"10.2807\/1560-7917.ES.2020.25.22.2001010","article-title":"SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020","volume":"25","author":"Belot","year":"2020","journal-title":"Euro Surveill"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e11064","DOI":"10.7759\/cureus.11064","article-title":"Multisystem inflammatory syndrome in children, the real disease of COVID-19 in pediatrics - a multicenter case series from Al-Ahsa, Saudi Arabia","volume":"12","author":"Almoosa","year":"2020","journal-title":"Cureus."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.15585\/mmwr.mm6932e2","article-title":"COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July","volume":"69","author":"Godfred-Cato","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1002\/art.41454","article-title":"American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2","volume":"73","author":"Henderson","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1046\/j.1365-2796.2003.01225.x","article-title":"Oral direct thrombin inhibitors in clinical development","volume":"254","author":"Gustafsson","year":"2003","journal-title":"J Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/infdis\/jiq136","article-title":"Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a \u201cnew\u201d virus associated with Kawasaki disease","volume":"203","author":"Rowley","year":"2011","journal-title":"J Infect Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fped.2018.00374","article-title":"The epidemiology and pathogenesis of Kawasaki disease","volume":"6","author":"Rowley","year":"2018","journal-title":"Front Pediatr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fped.2019.00018","article-title":"Causes of Kawasaki disease-from past to present","volume":"7","author":"Nagata","year":"2019","journal-title":"Front Pediatr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1365-2249.2005.02821.x","article-title":"Immunological profile of peripheral blood lymphocytes and monocytes\/macrophages in Kawasaki disease","volume":"141","author":"Matsubara","year":"2005","journal-title":"Clin Exp Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1046\/j.1365-2249.2000.01321.x","article-title":"CD14+CD16+ monocyte subpopulation in Kawasaki disease","volume":"121","author":"Katayama","year":"2000","journal-title":"Clin Exp Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1440-1827.2001.01202.x","article-title":"Maturation of macrophages from peripheral blood monocytes in Kawasaki disease: immunocytochemical and immunoelectron microscopic study","volume":"51","author":"Ariga","year":"2001","journal-title":"Pathol Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1440-1827.1991.tb01620.x","article-title":"Kawasaki disease. With particular emphasis on arterial lesions","volume":"41","author":"Naoe","year":"1991","journal-title":"Acta Pathol Jpn."},{"key":"B36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1272\/jnms.76.124","article-title":"Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis?","volume":"76","author":"Fukazawa","year":"2009","journal-title":"J Nippon Med Sch."},{"key":"B37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/MPG.0000000000000771","article-title":"Aortic intima-media thickness as an early marker of atherosclerosis in children with inflammatory bowel disease","volume":"61","author":"Aloi","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/HYPERTENSIONAHA.109.192639","article-title":"Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association","volume":"54","author":"Urbina","year":"2009","journal-title":"Hypertension."},{"key":"B39","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2337\/dc08-9018","article-title":"Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation","volume":"31","author":"Brunzell","year":"2008","journal-title":"Diabetes Care."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA."},{"key":"B41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12519-016-0023-0","article-title":"Meta-analysis of risk factors associated with atherosclerosis in patients with Kawasaki disease","volume":"12","author":"Zhang","year":"2016","journal-title":"World J Pediatr."},{"key":"B42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3345\/kjp.2014.57.5.217","article-title":"Cardiovascular risk factors of early atherosclerosis in school-aged children after Kawasaki disease","volume":"57","author":"Cho","year":"2014","journal-title":"Korean J Pediatr."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00246-017-1626-5","article-title":"Mid-term risk for subclinical atherosclerosis and chronic myocarditis in children with Kawasaki disease and transient coronary abnormalities","volume":"38","author":"Parihar","year":"2017","journal-title":"Pediatr Cardiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1042\/CS20180306","article-title":"Atherosclerosis and inflammation: overview and updates","volume":"132","author":"Geovanini","year":"2018","journal-title":"Clin Sci (Lond)."},{"key":"B45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jacc.2007.03.033","article-title":"Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study","volume":"50","author":"Meuwese","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jacc.2003.08.030","article-title":"Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis","volume":"43","author":"Cheung","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"248.e1","DOI":"10.1016\/j.jpeds.2007.03.056","article-title":"Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?","volume":"151","author":"McCrindle","year":"2007","journal-title":"J Pediatr."},{"key":"B48","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.1161\/01.CIR.101.1.e16","article-title":"Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III","volume":"101","author":"Greenland","year":"2000","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/RHU.0000000000000754","article-title":"Carotid intima-media thickness and lipid profile in children with Kawasaki disease: a single-center follow-up study after a mean duration of 6.9 years","volume":"24","author":"Gopalan","year":"2018","journal-title":"J Clin Rheumatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2017.03.022","article-title":"Increased aortic intima-media thickness following Kawasaki disease","volume":"260","author":"Chen","year":"2017","journal-title":"Atherosclerosis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.jpeds.2013.04.046","article-title":"Endothelial dysfunction in children within 5 years after onset of Kawasaki disease","volume":"163","author":"Ishikawa","year":"2013","journal-title":"J Pediatr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00296-013-2820-2","article-title":"Carotid intima-media thickness in children with Kawasaki disease","volume":"34","author":"Meena","year":"2014","journal-title":"Rheumatol Int."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.jacc.2013.04.090","article-title":"Vascular health in Kawasaki disease","volume":"62","author":"Selamet Tierney","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jpeds.2009.04.054","article-title":"Atherosclerosis in survivors of Kawasaki disease","volume":"155","author":"Gupta-Malhotra","year":"2009","journal-title":"J Pediatr."},{"key":"B55","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4070\/kcj.2009.39.7.264","article-title":"Carotid intima-media thickness and pulse wave velocity after recovery from Kawasaki disease","volume":"39","author":"Lee","year":"2009","journal-title":"Korean Circ J."},{"key":"B56","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s00246-008-9329-6","article-title":"Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease","volume":"30","author":"Noto","year":"2009","journal-title":"Pediatr Cardiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jpeds.2007.03.057","article-title":"Subclinical atherosclerosis, but normal autonomic function after Kawasaki disease","volume":"151","author":"Dalla Pozza","year":"2007","journal-title":"J Pediatr."},{"key":"B58","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jjcc.2019.06.015","article-title":"Virtual histology intravascular ultrasound evaluation of coronary artery lesions within 1 year and more than 10 years after the onset of Kawasaki disease","volume":"75","author":"Watanabe","year":"2020","journal-title":"J Cardiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/j.1651-2227.2009.01334.x","article-title":"Endothelial progenitor cells and arterial functions in the late convalescence period of Kawasaki disease","volume":"98","author":"Liu","year":"2009","journal-title":"Acta Paediatr."},{"key":"B60","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10067-007-0808-6","article-title":"High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease","volume":"27","author":"Borzutzky","year":"2008","journal-title":"Clin Rheumatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation."},{"key":"B62","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1177\/0003319713502392","article-title":"Endothelial and platelet function in children with previous Kawasaki disease","volume":"65","author":"Laurito","year":"2014","journal-title":"Angiology."},{"key":"B63","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jpeds.2014.06.017","article-title":"Lipoprotein particle concentrations in children and adults following Kawasaki disease","volume":"165","author":"Lin","year":"2014","journal-title":"J Pediatr."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"key":"B66","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation."},{"key":"B68","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.atherosclerosis.2010.02.007","article-title":"Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy","volume":"211","author":"Schmidt-Lucke","year":"2010","journal-title":"Atherosclerosis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/0961203316662719","article-title":"Short-term atorvastatin therapy improves arterial stiffness of middle-aged systemic lupus erythematosus patients with pathological pulse wave velocity","volume":"26","author":"Castejon","year":"2017","journal-title":"Lupus."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1470320319868890","DOI":"10.1177\/1470320319868890","article-title":"Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension - a randomised double-blind, placebo controlled crossover study","volume":"20","author":"Ruszkowski","year":"2019","journal-title":"J Renin Angiotensin Aldosterone Syst."},{"key":"B71","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s12350-018-1278-8","article-title":"Anti-inflammatory effect of statin in coronary aneurysms late after Kawasaki disease","volume":"26","author":"Bekki","year":"2019","journal-title":"J Nucl Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12519-014-0498-5","article-title":"Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease","volume":"10","author":"Duan","year":"2014","journal-title":"World J Pediatr."},{"key":"B73","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00246-013-0746-9","article-title":"Atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms","volume":"35","author":"Niedra","year":"2014","journal-title":"Pediatr Cardiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"689360","DOI":"10.1155\/2014\/689360","article-title":"The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int J Inflam."},{"key":"B75","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopha.2009.02.006","article-title":"Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation","volume":"63","author":"Fukuda","year":"2009","journal-title":"Biomed Pharmacother."},{"key":"B76","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10557-008-6097-8","article-title":"Secondary prevention after acute myocardial infarction and coronary revascularisation: focus on Angiotensin converting enzyme inhibitors","volume":"22","author":"Kaski","year":"2008","journal-title":"Cardiovasc Drugs Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.3390\/ijms20205202","article-title":"Carvedilol ameliorates experimental atherosclerosis by regulating cholesterol efflux and exosome functions","volume":"20","author":"Chen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B78","doi-asserted-by":"crossref","first-page":"795","DOI":"10.36290\/vnl.2019.138","article-title":"Atherosclerosis and beta-blockade: a forgotten option?","volume":"65","author":"Vrabl\u00edk","year":"2020","journal-title":"Vnitr Lek."},{"key":"B79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/eurheartj\/17.suppl_B.24","article-title":"Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection","volume":"17","author":"Feuerstein","year":"1996","journal-title":"Eur Heart J."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.671198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T13:53:46Z","timestamp":1671890026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.671198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":79,"alternative-id":["10.3389\/fcvm.2021.671198"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.671198","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"article-number":"671198"}}